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CASE REPORT
Hepatosplenic tuberculosis simulating 
secondary malignant lesions with cholangitis
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Abstract 
Background: Hepatic and/or splenic tuberculosis may simulate much pathology including malignancies, which 
can roam the diagnosis. Biopsy is necessary for diagnosis. The treatment allows healing and a cleaning of radiological 
lesions.
Case presentation: We report a case of a 48-old-black Senegalese woman, immunocompetent, hospitalized for 
febrile jaundice and poor general condition. Imaging and hepatic biopsy showed hepatosplenic tuberculosis with 
cholangitis, simulating secondary malignancies lesions. The outcome was favorable under treatment.
Conclusion: In front of hepatic nodular lesions simulating malignancies in a tuberculosis endemic areas, achieving a 
liver biopsy helps rectify the diagnosis.
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Background
Tuberculosis (TB) is endemic in our country. In the abdo-
men, the localization in the liver is rare, far behind the 
peritoneal and intestinal sites. Furthermore, tubercular 
cholangitis is rare. We report a case of hepatosplenic 
tuberculosis simulating secondary malignancies lesions 
associated with cholangitis in a multifocal tuberculosis 
context.
Case report
A 48 years old-black Senegalese woman was hospitalized 
in June 2011 for cholestatic jaundice, right upper quad-
rant pain, fever and weak general condition with weight 
loss of 15 kg in 2 months. She had no medical or surgi-
cal history or pre-existing medical condition. On physi-
cal examination, she had jaundice and fever (38.5  °C). 
The abdomen was soft, painful to palpation of the right 
upper quadrant with hepatomegaly. She had no periph-
eral lymph nodes or splenomegaly. Laboratory inves-
tigations showed a discrete cytolysis with aspartate 
aminotransferase (AST)  =  62  IU/l (2  N), alanine ami-
notransferase (ALT) =  49  IU/l (1,3  N), cholestasis with 
alkaline phosphatase (ALP) to 367  IU/l (2.7  N), GGT 
291  IU/l (3.4  N), total bilirubin : 118.3  mg/l, with con-
jugated fraction to 77.3  mg/l, without liver deficiency 
[prothrombin time (PT) = 81 % albumin = 36 g/l]. There 
was an inflammation, with an erythrocyte sedimentation 
rate of 33 mm in the first hour, a serum fibrin to 4.1 g/l, 
and polyclonal hypergammaglobulinemia (31  g/l). The 
blood cell count and renal functions were normal. The 
alpha-fetoprotein levels were normal (3.7 ng/ml). Search 
of acid-fast bacilli by gastric aspirate was negative. The 
viral serology [hepatitis B virus (HBV), hepatitis C virus 
(HCV), human immunodeficiency virus (HIV), human 
T-lymphotropic virus 1 (HTLV1)] were negative. The 
urine cultures were sterile, without hematuria or pyuria.
The chest x-ray was normal. Abdominal ultrasound 
showed a focal lesion of the left liver measuring 4 cm with 
metastatic appearance, several poorly defined hypoechoic 
areas, liver hilar lymphadenopathy and dilation of intra-
hepatic bile conduct. The thoraco-abdominal CT scan 
objectified multiple hypovascular nodules infiltrating the 
entire liver parenchyma (Fig. 1a, b), spleen nodules, pul-
monary calcifications, mediastinal and abdominal lymph 
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nodes. These nodules had a late enhancement of nonspe-
cific appearance on Magnetic Resonance Imaging (MRI) 
with an amputation aspect of the biliary tree probably 
due to infiltration, realizing cholangitis (Fig. 2a, b). Liver 
biopsy showed hepatitis with reactional appearance with 
light activity and portal fibrosis without septa, cholesta-
sis, epithelioid and giant cell granulomas without case-
ous necrosis. A multifocal tuberculosis (liver, bile ducts, 
spleen and lymph node) associated with cholangitis were 
diagnosed and treatment started with quadritherapy 
based on rifampicin (10  mg/kg/day), isoniazid (5  mg/
kg/day), ethambutol (20  mg/kg/day) and pyrazinamide 
(30 mg/kg/day). A week later, the patient presented with 
severe acute drug hepatitis with ALT = 528 IU/L (13 N), 
AST = 973 IU/l (31 N) and PT 44 %, leading to treatment 
discontinuation. After normalization of these param-
eters after 10  days triple therapy combining rifampicin, 
ethambutol and levofloxacin was introduced with a 
good evolution: clinical improvement, normalization of 
liver function tests. After 4 months of triple therapy and 
5 months of combination therapy (rifampicin and etham-
butol), the outcome was favorable with disappearance of 
hepatic and splenic lesions on CT scan (Fig. 3).  
Discussion
Tuberculosis is a serious public health problem in our 
country. Abdominal localization ranks 4th behind lung, 
pleural and ganglion tuberculosis in our hospital [1]. 
Peritoneal TB is the most common abdominal form, fol-
lowed by intestinal involvement. Isolated hepatobiliary 
TB is rare, due to the lack of oxygen in the liver, which 
is not favorable to the development of mycobacteria [2]. 
Liver infection can occur by hematogenous dissemina-
tion from the hepatic artery [3]. It can also go through 
the portal circulation, leading to macronodular, pseudo-
tumoral or abscesses forms, often associated with intes-
tinal localization [4]. It can be complicated with portal 
hypertension [5]. In our patient, the presence of hepatic 
and splenic macronodular lesions would be in favor of 
portal vein dissemination.
Fig. 1 Multiple hepatic and splenic nodules hypodenses in the scanner (a) and hypointense on MRI with a delayed enhancement (b)
Fig. 2 a Bile ducts amputation and b dilatation suggestive to cholangitis
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Clinical features usually associate hepatomegaly and/
or splenomegaly with fever, dull pain in the right upper 
quadrant, jaundice and weak general condition, as in 
our patient. Exceptionally, ascites may be associated. 
However, these symptoms may be missing, especially in 
primitive forms. Hasan reported a case of isolated hepat-
osplenic TB without fever, shivering or jaundice, but only 
with abdominal pain and weight loss [6]. Disturbance of 
liver function tests resulting mostly to cholestasis and 
sometimes cytolysis. In our case, cytolysis was minimal 
and cholestasis marked. Liver tests can be normal despite 
the hepatic localization of TB [6].
In imaging, lesions are not specific [7]. In micronodular 
form, lesions are hypoechoic on ultrasound, punctate and 
hypodense on CT scan with less than 2 mm in size, scat-
tered in the liver and the spleen. In macronodular forms, 
as described in our case, the ultrasound shows one or 
more masses with echogenicity and variable size, usually 
hypoechoic. In CT scan, the early lesions are isodense, 
become hypodense and eventually calcified. The con-
trast medium injection causes an annular enhancement 
[7]. On MRI, the most evocative aspect is a hyperin-
tense lesion on the periphery, with lesser intensity at the 
center on T2-weighted sequences, and which enhances 
the periphery after contrast injection [7]. Spleen loca-
tions often associated, as in our case, in the form of 
hypoechoic/hypodense regular lesions, or irregular ane-
choic (abscess) or calcified nodule should be sought [8]. 
Furthermore imaging can show hepatic TB like a tumor 
mass as described by Kuçukmetin [9]. MRI also showed 
lesions suggestive of secondary sclerosing cholangitis 
in this context to tuberculosis. Tuberculous cholangitis 
is rare. This would be the cause of persistent jaundice 
in our patient. Imaging findings can vary from bile duct 
thickening, biliary dilatation and long and smooth stric-
tures to frank obstructive biliopathy [7]. In the serie of 
Amarapurkar, 39.4  % of patients with hepatic TB, had 
biliary lesions, but only 5.2 % with biliary strictures, and 
the majority had biliary obstruction due to lymph node 
masses (31.5 %) [10]. In our patient, the bile ducts stric-
tures were due to tuberculous infiltration.
The differential diagnosis will be made with secondary 
locations carcinoma, lymphoproliferative disorders and 
other granulomatosis. Diagnosis is based on histology 
through biopsy with a fine needle of the most accessible 
lesions. Epithelioid granuloma and giant cells are found 
in 80–100 % of cases, with caseous necrosis in 30–83 % of 
cases, or acid fast bacilli (AFB) in 59 % of cases [8]. PCR 
techniques detecting Mycobacterium tuberculosis may 
help the diagnosis [3]. The diagnosis of hepatic tuber-
culosis requires looking for immunosuppression. Our 
patient did not consume alcohol, was not diabetic, was 
not taking corticosteroids or immunosuppressive treat-
ment and retroviral serology were negative to HIV and 
HTLV-1.
Treatment is based on TB medicines, according to 
different protocols. In Senegal, the quadruple therapy 
(isoniazid, rifampicin, éthambuthol pyrazinamide) for 
2  months, followed by combination therapy (isonia-
zid, rifampicin) for 4 months, is the standard treatment. 
Some authors recommend prolonging treatment for 
12  months [11]. In our case, the patient received con-
ventional quadruple therapy which was stopped because 
of liver toxicity which can occur during treatment with 
a frequency ranging from 2 to 28 % [12]. Female gender, 
malnutrition, an existing liver disease, conditions met in 
our patient, are among others, factors favoring the occur-
rence of toxicity [12]. In our patient, it was decided to 
stop definitively isoniazid and pyrazinamide which are 
the most purveyors drugs hepatotoxicity, and introduce 
a second line anti-TB drugs (levofloxacin) associated 
with rifampicin and ethambutol, with good evolution. 
In hepatic or hepatosplenic tuberculosis, evolution is 
favorable in 67–100 % of cases with radiological healing 
and cleaning [10, 11] of lesions.
Conclusions
Hepatic tuberculosis simulates many diseases, making 
diagnosis often difficult. Think about it in a suggestive 
clinical and epidemiological context. Imaging data is not 
specific and liver biopsy is always necessary. Evolution is 
often favorable if treatment is well conducted by moni-
toring the hepatotoxicity of antituberculosis drugs.
Fig. 3 Control after 9 months of TB treatment
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